A comparison of sfa treatment with zilver ptx in diabetics vs non diabetics. clinical and functional results after 24 months

J Cardiovasc Surg

30 March Mar 2015 11 years ago
  • Oberto S, Cetta F, Trabattoni P, Zoli S, Tavano D, Rossi F, Clerici G, Airoldi F, Spirito R, Losa S
QR Code
Prospective single--arm study, aimed at evaluating safety and effectiveness at 12 and 24 months of the paclitaxel eluting nitinol stent (Zilver PTX), and focused in particular on the treatment of complex lesions and/or diabetic patients.